Difference between revisions of "Dissolution testing"
From LIMSWiki
Jump to navigationJump to searchShawndouglas (talk | contribs) (Recreated article due to necessary redirect.) |
Shawndouglas (talk | contribs) m (Internal link.) |
||
| Line 1: | Line 1: | ||
In the pharmaceutical industry, drug '''dissolution testing''' is routinely used to provide critical | In the pharmaceutical industry, drug '''dissolution testing''' is routinely used to provide critical in vitro drug release [[information]] for both quality control purposes, i.e., to assess batch-to-batch consistency of solid oral dosage forms such as tablets, and drug development, i.e., to predict [[in vivo]] drug release profiles.<ref name="Bai1">{{cite journal|author=Ge Bai, Yimin Wang and Piero M. Armenante |title=Velocity profiles and shear strain rate variability in the USP Dissolution Testing Apparatus 2 at Different Impeller Agitation Speeds |journal=International Journal of Pharmaceutics |volume=403 |issue=1–2 |pages=1–14 |year=17 January 2011 |doi=10.1016/j.ijpharm.2010.09.022}}</ref> | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
Revision as of 22:14, 13 September 2013
In the pharmaceutical industry, drug dissolution testing is routinely used to provide critical in vitro drug release information for both quality control purposes, i.e., to assess batch-to-batch consistency of solid oral dosage forms such as tablets, and drug development, i.e., to predict in vivo drug release profiles.[1]
References
- ↑ Ge Bai, Yimin Wang and Piero M. Armenante (17 January 2011). "Velocity profiles and shear strain rate variability in the USP Dissolution Testing Apparatus 2 at Different Impeller Agitation Speeds". International Journal of Pharmaceutics 403 (1–2): 1–14. doi:10.1016/j.ijpharm.2010.09.022.
